Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10

Proceedings of the National Academy of Sciences of the United States of America

Volumn 82, Issue 13, 1985, Pages 4513-4516

  Folkers, K ^a   Wolaniuk, J ^a   Simonsen, R ^a   Morishita, M ^b   Vadhanavikit, S ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; UBIQUINONE;

CARDIOGRAPHY; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSIS; DRUG INDICATION; DRUG THERAPY; HEART; HEART FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MUSCLE; MUSCLE DISEASE; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; REVIEW; THERAPY;

ADMINISTRATION, ORAL; CARDIAC OUTPUT; CHARCOT-MARIE-TOOTH DISEASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; HEART; HUMANS; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES; STROKE VOLUME; UBIQUINONE;

EID: 0021971121     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.82.13.4513     Document Type: Article

References (0)